This inventor holds 1 USPTO granted patent. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations of Srinivasrao Ganipisetti
Introduction
Srinivasrao Ganipisetti is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of bioscience and biotechnology. His work primarily focuses on developing compositions that address inflammatory diseases.
Latest Patents
Srinivasrao Ganipisetti holds a patent for an "Anti-inflammatory composition comprising acylhydrazone derivative." This invention relates to a composition designed to prevent, alleviate, or treat inflammatory diseases. The active ingredient in this composition is an acylhydrazone derivative compound, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The invention effectively inhibits inflammatory cytokines and signaling pathways, thereby alleviating symptoms of inflammatory diseases such as dermatitis. This composition can be effectively used for the prevention, alleviation, or treatment of such diseases.
Career Highlights
Srinivasrao Ganipisetti is associated with the Korea Research Institute of Bioscience and Biotechnology. His work at this institution has allowed him to focus on innovative solutions in the field of health and medicine. His research has led to advancements that can significantly impact the treatment of inflammatory conditions.
Collaborations
Srinivasrao has collaborated with notable colleagues, including Joonsung Hwang and Jong Seog Ahn. These collaborations have contributed to the development of his innovative patent and further advancements in their shared field of research.
Conclusion
Srinivasrao Ganipisetti's contributions to the field of bioscience and biotechnology are noteworthy. His patent for an anti-inflammatory composition showcases his commitment to addressing significant health challenges. His work continues to pave the way for innovative treatments in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
